{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:03:28Z","timestamp":1769004208897,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jid.2020.03.938","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T15:21:12Z","timestamp":1585408872000},"page":"2298-2301.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Loss of Wild-Type CDKN2A Is an Early Event in the Development of Melanoma in FAMMM Syndrome"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-7974","authenticated-orcid":false,"given":"Eirini","family":"Christodoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3530-3725","authenticated-orcid":false,"given":"Rogier J.","family":"Nell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1437-214X","authenticated-orcid":false,"given":"Rob M.","family":"Verdijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5210-9150","authenticated-orcid":false,"given":"Nelleke A.","family":"Gruis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-9256","authenticated-orcid":false,"given":"Pieter A.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7019-6673","authenticated-orcid":false,"given":"Remco","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.03.938_bib1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/bjc.1990.209","article-title":"Systemic cancer and the FAMMM syndrome","volume":"61","author":"Bergman","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2020.03.938_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ejhg.2013.118","article-title":"The Genome of the Netherlands: design, and project goals","volume":"22","author":"Boomsma","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jid.2020.03.938_bib3","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.03.938_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008390-199506000-00005","article-title":"CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families","volume":"5","author":"Gruis","year":"1995","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2020.03.938_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ng0795-351","article-title":"Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds","volume":"10","author":"Gruis","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2020.03.938_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008390-199902000-00004","article-title":"Melanoma development in relation to non-functional p16\/INK4A protein and dysplastic naevus syndrome in Swedish melanoma kindreds","volume":"9","author":"Hashemi","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jid.2020.03.938_bib7","first-page":"1649","article-title":"Chromosome 9 deletion in sporadic and familial melanomas in\u00a0vivo","volume":"9","author":"Isshiki","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.03.938_bib8","article-title":"Quantification of DNA methylation using methylation-sensitive restriction enzymes and multiplex digital PCR","author":"Nell","year":"2019","journal-title":"bioRxviv"},{"key":"10.1016\/j.jid.2020.03.938_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccell.2018.06.005","article-title":"Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution","volume":"34","author":"Shain","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2020.03.938_bib10","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2020.03.938_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0959-437X(99)80004-5","article-title":"The INK4A\/ARF locus and its two gene products","volume":"9","author":"Sharpless","year":"1999","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.jid.2020.03.938_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1019599629895","article-title":"Alteration of chromosome 9p21 and\/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States)","volume":"13","author":"Tran","year":"2002","journal-title":"Cancer Causes Control CCC"},{"key":"10.1016\/j.jid.2020.03.938_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116371","article-title":"Digital PCR validates 8q dosage as prognostic tool in uveal melanoma","volume":"10","author":"Versluis","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jid.2020.03.938_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ccell.2018.05.014","article-title":"Bi-allelic loss of CDKN2A initiates melanoma invasion via BRN2 activation","volume":"34","author":"Zeng","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2020.03.938_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/cup.13530","article-title":"BRCA1-associated protein (BAP1)-inactivated melanocytic tumors","volume":"46","author":"Zhang","year":"2019","journal-title":"J\u00a0Cutan Pathol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20312057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20312057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:35:41Z","timestamp":1613608541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20312057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0022202X20312057"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.03.938","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of Wild-Type CDKN2A Is an Early Event in the Development of Melanoma in FAMMM Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.03.938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}